Pfizer Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.156x

Pfizer Limited cash flow conversion efficiency. Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Pfizer Limited (2005–2026)

Cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pfizer Limited stock quote for real-time trading data and today's change.

Pfizer Limited Cash Flow Conversion Ratio Explained

Pfizer Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Pfizer Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency. Also see Pfizer Limited market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Jiangsu Dingsheng New Material Joint-Stock Co Ltd SHG:603876	0.012x
Beijing Teamsun Technology Co Ltd SHG:600410	0.004x
SmartStop Self Storage REIT, Inc. NYSE:SMA	0.019x
Outokumpu Oyj HE:OUT1V	0.015x
Zenas BioPharma, Inc. Common Stock NASDAQ:ZBIO	-0.232x
Dime Community Bancshares, Inc. NYSE:DCOM	0.037x
CETC Energy Joint Stock Co Ltd SHG:600877	-0.019x
Array Digital Infrastructure, Inc. NYSE:AD	0.013x

Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. Review PFIZER FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs42.03 Billion ≈ $454.53 Million	Rs11.44 Billion ≈ $123.67 Million	0.272x	+73.94%
2025-03-31	Rs42.17 Billion ≈ $456.10 Million	Rs6.60 Billion ≈ $71.35 Million	0.156x	+119.00%
2024-03-31	Rs35.96 Billion ≈ $388.84 Million	Rs2.57 Billion ≈ $27.78 Million	0.071x	-35.59%
2023-03-31	Rs32.07 Billion ≈ $346.86 Million	Rs3.56 Billion ≈ $38.47 Million	0.111x	-52.38%
2022-03-31	Rs28.64 Billion ≈ $309.78 Million	Rs6.67 Billion ≈ $72.14 Million	0.233x	+30.42%
2021-03-31	Rs23.93 Billion ≈ $258.80 Million	Rs4.27 Billion ≈ $46.21 Million	0.179x	+87.62%
2020-03-31	Rs33.95 Billion ≈ $367.21 Million	Rs3.23 Billion ≈ $34.95 Million	0.095x	+193.03%
2019-03-31	Rs30.11 Billion ≈ $325.66 Million	Rs978.10 Million ≈ $10.58 Million	0.032x	-73.73%
2018-03-31	Rs26.83 Billion ≈ $290.18 Million	Rs3.32 Billion ≈ $35.88 Million	0.124x	-9.03%
2017-03-31	Rs24.19 Billion ≈ $261.59 Million	Rs3.29 Billion ≈ $35.56 Million	0.136x	-16.22%
2016-03-31	Rs21.18 Billion ≈ $229.05 Million	Rs3.44 Billion ≈ $37.16 Million	0.162x	+182.10%
2015-03-31	Rs19.73 Billion ≈ $213.37 Million	Rs1.13 Billion ≈ $12.27 Million	0.058x	-71.41%
2014-03-31	Rs6.58 Billion ≈ $71.20 Million	Rs1.32 Billion ≈ $14.32 Million	0.201x	+4060.27%
2013-03-31	Rs16.94 Billion ≈ $183.25 Million	Rs-86.07 Million ≈ $-930.79K	-0.005x	-127.10%
2012-03-31	Rs13.05 Billion ≈ $141.10 Million	Rs244.59 Million ≈ $2.65 Million	0.019x	-86.64%
2011-03-31	Rs11.63 Billion ≈ $125.82 Million	Rs1.63 Billion ≈ $17.66 Million	0.140x	+86.88%
2010-03-31	Rs9.94 Billion ≈ $107.53 Million	Rs746.73 Million ≈ $8.08 Million	0.075x	-71.54%
2009-03-31	Rs9.01 Billion ≈ $97.45 Million	Rs2.38 Billion ≈ $25.71 Million	0.264x	+941.98%
2008-03-31	Rs6.50 Billion ≈ $70.26 Million	Rs164.53 Million ≈ $1.78 Million	0.025x	-90.96%
2007-03-31	Rs4.40 Billion ≈ $47.56 Million	Rs1.23 Billion ≈ $13.32 Million	0.280x	+2.51%
2006-03-31	Rs3.76 Billion ≈ $40.66 Million	Rs1.03 Billion ≈ $11.11 Million	0.273x	+6.40%
2005-03-31	Rs3.40 Billion ≈ $36.72 Million	Rs872.08 Million ≈ $9.43 Million	0.257x	--

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General

Market Cap

$1.80 Billion

Rs166.46 Billion INR

Market Cap Rank

#6296 Global

#282 in India

Share Price

Rs3638.70

Change (1 day)

-1.33%

52-Week Range

Rs3612.30 - Rs5197.80

All Time High

Rs6318.30